<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<!-- InstanceParam name="id" type="text" value="undefined" --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="HICPAC, 2008 Guideline for Disinfection and Sterilization in Healthcare Facilities, " />
<meta name="DC.Subject" 	content="The Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008, presents evidence-based recommendations on the preferred methods for cleaning, disinfection and sterilization of patient-care medical devices and for cleaning and disinfecting the healthcare environment." />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />
<!-- InstanceEndEditable -->
<meta name="template.version" content="2.5.2" />
<!-- @package: TemplatePackage 'B' @version: "2.5.2" -->
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - Disinfection &amp; Sterilization Guideline:Contaminated Devices - HICPAC</title>
<!-- InstanceEndEditable -->
<style type="text/css" media="tv">
empty{color:#000};@import "../../TemplatePackage/css/B/wysiwyg/wysiBaseHome.css"/**/;
</style>
<style type="text/css" media="screen, projection">
@import "../../TemplatePackage/css/B/base-float.css"/**/;
</style>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/share.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/external.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/plugins.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->
<style type="text/css" media="print">@import "../../TemplatePackage/css/B/print.css";</style>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!-- Local Topic Styles -->
<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->

<!-- InstanceEndEditable -->
</head>
<body id="undefined" class="secondTier">

<div id="skipmenu">
	<a href="3_2contaminatedDevices.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="3_2contaminatedDevices.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="3_2contaminatedDevices.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="3_2contaminatedDevices.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="3_2contaminatedDevices.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div class="top"></div>
	<div id="wrapper-inner">
		<div id="branding">
			<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC 24/7: Saving Lives. Protecting People.&trade;" border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>
	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
			<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="content">
			<div id="content-inner">
				
				<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
				<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" -->
				<div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="../BSI/BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="../BSI/toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="../BSI/01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="../BSI/02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="../BSI/03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="../BSI/04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="../BSI/05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="../BSI/06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="../BSI/07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="../BSI/bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="../BSI/13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="../BSI/11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="../BSI/12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="../norovirus/002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="../norovirus/003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="../norovirus/001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="../norovirus/004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="../norovirus/005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="../norovirus/006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="../norovirus/007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="../norovirus/008_norovirus-background.html">Background					     </a></li>
					   <li><a href="../norovirus/009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="../norovirus/010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="../norovirus/011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="../norovirus/012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="../norovirus/013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="../norovirus/norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="../norovirus/norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="../norovirus/tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="../norovirus/norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="../norovirus/norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="../norovirus/norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="toc.html">Table of Contents</a></li>
	              <li><a href="1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="5_0cleaning.html">Cleaning</a></li>
                  <li><a href="6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="19_00glossary.html">Glossary</a></li>
                  <li><a href="table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="table_2.html">Table 2, 3</a></li>
                      <li><a href="fig_1.html">Figure 1</a></li>
                      <li><a href="table_4.html">Table 4</a></li>
                      <li><a href="table_5.html">Table 5</a></li>
                      <li><a href="table_6.html">Table 6</a></li>
                      <li><a href="table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="../2007IP/2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="../2007IP/2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="../2007IP/2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="../2007IP/2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="../2007IP/2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="../2007IP/2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="../2007IP/2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="../2007IP/2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="../2007IP/2007ip_table2.html">Table 2</a></li>
                            <li><a href="../2007IP/2007ip_table3.html">Table 3</a></li>
                            <li><a href="../2007IP/2007ip_table4.html">Table 4</a></li>
                            <li><a href="../2007IP/2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="../2007IP/2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="../2007IP/2007ip_glossary.html">Glossary</a></li>
                        <li><a href="../2007IP/2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="../cauti/001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="../cauti/002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="../cauti/02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="../cauti/003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="../cauti/002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="../cauti/003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="../cauti/004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="../cauti/005_background.html">V. Background</a></li>
                      <li><a href="../cauti/006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="../cauti/007_methods.html">VII. Methods</a></li>
                      <li><a href="../cauti/008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="../cauti/009_cauti2009_References.html">References</a></li>
                      <li><a href="../cauti/010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="../SSI/001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="../SSI/toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="../SSI/002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="../SSI/003_SSI.html">Microbiology</a></li>
                <li><a href="../SSI/004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="../SSI/005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="../SSI/006_SSI.html">SSI Surveillance </a></li>
                <li><a href="../SSI/007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="../SSI/ref-SSI.html">References </a></li>
                <li><a href="../SSI/figure-SSI.html">Figure</a></li>
                <li><a href="../SSI/table1-SSI.html">Table 1</a></li>
                <li><a href="../SSI/table2-SSI.html">Table 2</a></li>
                <li><a href="../SSI/table3-SSI.html">Table 3</a></li>
                <li><a href="../SSI/table4-SSI.html">Table 4</a></li>
                <li><a href="../SSI/table5-SSI.html">Table 5</a></li>
                <li><a href="../SSI/table6-SSI.html">Table 6</a></li>
                <li><a href="../SSI/table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

				
				<!-- InstanceEndEditable -->
				</div>
				
				<!-- ########## BREADCRUMBS START HERE ########## -->
				<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
				<div id="content-main">
					<div class="main-inner">
						
						<!-- InstanceBeginEditable name="content-main" -->
					 <h1>Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008</h1>
					
                     
                       
<div id="onthispage">
<div class="rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>On this Page</h4>
<div class="subc">
<ul>
 <li><a href="3_2contaminatedDevices.html#">Inactivation of Bioterrorist Agents</a> </li>
 <li><a href="3_2contaminatedDevices.html#a2">Toxicological, Environmental and Occupational Concerns</a> </li>
    <li><a href="3_2contaminatedDevices.html#a3">Disinfection in Ambulatory Care, Home Care, and the Home</a></li>
    <li><a href="3_2contaminatedDevices.html#a4">Susceptibility of Antibiotic-Resistant Bacteria to Disinfectants
</a></li>
    
    
</ul>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>
 
 
   <p><a href="https://www.cdc.gov/hicpac/pdf/guidelines/Disinfection_Nov_2008.pdf" >Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 [PDF - 948 KB]</a></p>
                     
  
<h3>Disinfection of HBV-, HCV-, HIV- or TB-Contaminated Devices</h3>


<p>The  CDC recommendation for high-level disinfection of HBV-, HCV-, HIV- or TB-contaminated  devices is appropriate because experiments have demonstrated the effectiveness  of high-level disinfectants to inactivate these and other pathogens that might contaminate  semicritical devices <sup>61, 62, 73, 81, 105, 121,  125, 221-238</sup>.  Nonetheless, some healthcare facilities have  modified their disinfection procedures when endoscopes are used with a patient  known or suspected to be infected with HBV, HIV, or <em>M. tuberculosis</em> <sup>28, 239</sup>.  This is inconsistent with the concept of  Standard Precautions that presumes all patients are potentially infected with  bloodborne pathogens<sup>228</sup>.  Several studies have highlighted the  inability to distinguish HBV- or HIV-infected patients from noninfected  patients on clinical grounds<sup>240-242</sup>.  In addition, mycobacterial infection is  unlikely to be clinically apparent in many patients. In most instances,  hospitals that altered their disinfection procedure used EtO sterilization on  the endoscopic instruments because they believed this practice reduced the risk  for infection <sup>28, 239</sup>.  EtO is not routinely used for endoscope  sterilization because of the lengthy processing time. Endoscopes and other  semicritical devices should be managed  the same way regardless of whether the patient is known to be infected with  HBV, HCV, HIV or <em>M. tuberculosis</em>.</p>

<p>An evaluation of a manual  disinfection procedure to eliminate HCV from experimentally contaminated  endoscopes provided some evidence that cleaning and 2% glutaraldehyde for 20  minutes should prevent transmission <sup>236</sup>.  A study that used experimentally  contaminated hysteroscopes detected HCV by polymerase chain reaction (PCR) in  one (3%) of 34 samples after cleaning with a detergent, but no samples were  positive after treatment with a 2% glutaraldehyde solution for 20 minutes <sup>120</sup>.  Another study demonstrated  complete elimination of HCV (as detected by PCR) from endoscopes used on  chronically infected patients after cleaning and disinfection for 3&ndash;5 minutes  in glutaraldehyde <sup>118</sup>.  Similarly, PCR was used to  demonstrate complete elimination of HCV after standard disinfection of  experimentally contaminated endoscopes <sup>236</sup> and endoscopes used on HCV-antibody&ndash;positive patients had no detectable  HCV RNA after high-level disinfection <sup>243</sup>. The inhibitory activity of a phenolic and a chlorine compound on HCV  showed that the phenolic inhibited the binding and replication of HCV, but the  chlorine was ineffective, probably because of its low concentration and its  neutralization in the presence of organic matter <sup>244</sup>. </p>

                    <div class="margin">
 
         
           <p><a name="a2" id="a2"></a>          
                   
            </p>
            <p class="topOPage"><a href="3_2contaminatedDevices.html#">Top of Page</a></p> 
                    
                    
            
<h3>Disinfection in the Hemodialysis Unit</h3>


<p>Hemodialysis  systems include hemodialysis machines, water supply, water-treatment systems,  and distribution systems. During hemodialysis, patients have acquired  bloodborne viruses and pathogenic bacteria <sup>245-247</sup>.  Cleaning and disinfection are  important components of infection control in a hemodialysis center. EPA and FDA  regulate disinfectants used to reprocess hemodialyzers, hemodialysis machines,  and water-treatment systems.</p>

<p>Noncritical  surfaces (e.g., dialysis bed or chair, countertops, external surfaces of  dialysis machines, and equipment [scissors, hemostats,   clamps, blood pressure cuffs, stethoscopes]) should be disinfected  with an EPA-registered disinfectant unless the item is visibly contaminated  with blood; in that case a tuberculocidal agent (or a disinfectant with  specific label claims for HBV and HIV) or a 1:100 dilution of a hypochlorite  solution (500&ndash;600 ppm free chlorine) should be used <sup>246,  248</sup>.  This procedure accomplishes two goals: it  removes soil on a regular basis and maintains an environment that is consistent  with good patient care. Hemodialyzers are disinfected with peracetic acid,  formaldehyde, glutaraldehyde, heat pasteurization with citric acid, and  chlorine-containing compounds <sup>249</sup>.  Hemodialysis systems usually are disinfected by  chlorine-based disinfectants (e.g.,sodium  hypochlorite), aqueous formaldehyde, heat pasteurization, ozone, or peracetic  acid <sup>250, 251</sup>.  All products must be used  according to the manufacturers' recommendations.  Some dialysis systems use hot-water  disinfection to control microbial contamination.</p>

<p> At its high point, 82% of U.S.  chronic hemodialysis centers were reprocessing (i.e., reusing) dialyzers for  the same patient using high-level disinfection <sup>249</sup>.  However, one of the large  dialysis organizations has decided to phase out reuse and, by 2002 the percentage  of dialysis facilities reprocessing hemodialyzers had decreased to 63%  <sup>252</sup>.  The two commonly used  disinfectants to reprocess dialyzers were peracetic acid and formaldehyde; 72%  used peracetic acid and 20% used formaldehyde to disinfect hemodialyzers.  Another 4% of the facilities used either glutaraldehyde or heat pasteurization  in combination with citric acid <sup>252</sup>.  Infection-control  recommendations, including disinfection and sterilization and the use of  dedicated machines for hepatitis B surface antigen (HBsAg)-positive patients,  in the hemodialysis setting were detailed in two reviews <sup>245, 246</sup>.  The Association for the  Advancement of Medical Instrumentation(AAMI) has published recommendations for  the reuse of hemodialyzers<sup>253</sup>. </p>

                       
                        <p class="topOPage"><a href="3_2contaminatedDevices.html#">Top of Page</a></p> 
                       
                       
                        <p><a name="a3" id="a3"></a> </p>
                       
<h3>Inactivation of <em>Clostridium difficile</em></h3>


<p>The  source of health-care&ndash;associated acquisition of <em>Clostridium difficile</em> in nonepidemic settings has not been  determined. The environment and carriage on the hands of health-care personnel  have been considered possible sources of infection <sup>66, 254</sup>.  Carpeted rooms occupied by a patient with <em>C. difficile</em> were more heavily  contaminated with <em>C. difficile</em> than were  noncarpeted rooms <sup>255</sup>.  Because <em>C.  difficile</em> spore-production can increase when exposed to nonchlorine-based  cleaning agents and the spores are more resistant than vegetative cells to  commonly used surface disinfectants<sup>256</sup>, some investigators have  recommended use of dilute solutions of hypochlorite (1,600 ppm available  chlorine) for routine environmental disinfection of rooms of patients with <em>C. difficile</em>-associated diarrhea or  colitis <sup>257</sup>, to reduce the incidence of <em>C.  difficile</em> diarrhea <sup>258</sup>, or in units with high <em>C. difficile</em> rates. <sup>259</sup>  Stool samples of patients with symptomatic <em>C. difficile</em> colitis contain spores of  the organism, as demonstrated by ethanol treatment of the stool to reduce the  overgrowth of fecal flora when isolating <em>C.  difficile</em> in the laboratory<sup>260, 261</sup>.  <em>C.  difficile</em>-associated diarrhea rates were shown to have decreased markedly in  a bone-marrow transplant unit (from 8.6 to 3.3 cases per 1,000 patient-days)  during a period of bleach disinfection (1:10 dilution) of environmental  surfaces compared with cleaning with a quaternary ammonium compound. Because no  EPA-registered products exist that are specific  for inactivating <em>C. difficile</em> spores, use of diluted hypochlorite should  be considered in units with high <em>C.  difficile</em> rates. Acidified bleach and regular bleach (5000 ppm chlorine)  can inactivate 10<sup>6</sup> <em>C. difficile</em> spores in <u>&lt;</u>10  minutes <sup>262</sup>.  However,  studies have shown that asymptomatic patients constitute an important reservoir  within the health-care facility and that person-to-person transmission is the  principal means of transmission between patients. Thus, combined use of hand washing,  barrier precautions, and meticulous environmental cleaning with an  EPA-registered disinfectant (e.g., germicidal detergent) should effectively  prevent spread of the organism <sup>263</sup>. </p>

<p>Contaminated medical devices, such  as colonoscopes and thermometers,can be vehicles for transmission of <em>C.  difficile</em> spores <sup>264</sup>.  For this reason, investigators have studied  commonly used disinfectants and exposure times to assess whether current  practices can place patients at risk. Data demonstrate that 2% glutaraldehyde <sup>79,  265-267</sup> and  peracetic acid <sup>267,  268</sup> reliably  kill <em>C. difficile</em> spores using  exposure times of 5&ndash;20 minutes. <em>ortho</em>-Phthalaldehyde  and <u>&gt;</u>0.2% peracetic acid (WA Rutala, personal communication, April  2006) also can inactivate <u>&gt;</u>10<sup>4</sup> <em>C. difficile</em> spores in 10&ndash;12 minutes at 20ºC <sup>268</sup>.  Sodium  dichloroisocyanurate at a concentration of 1000 ppm available chlorine achieved  lower log10 reduction factors against <em>C. difficile</em> spores at 10 min, ranging from 0.7 to 1.5, than 0.26%  peracetic acid with log10 reduction factors ranging from 2.7 to 6.0268.  </p>


                   
                    <p class="topOPage"><a href="3_2contaminatedDevices.html#">Top of Page</a></p>
                    
                    <p><a name="a4" id="a4"></a> </p>
                      
<h3>OSHA Bloodborne Pathogen Standard</h3>


<p>In December 1991, OSHA promulgated a standard  entitled &quot;Occupational Exposure to Bloodborne Pathogens&quot; to eliminate or  minimize occupational exposure to bloodborne pathogens <sup>214</sup>. One component of this requirement is that all  equipment and environmental and working surfaces be cleaned and decontaminated  with an appropriate disinfectant after contact with blood or other potentially  infectious materials. Even though the OSHA standard does not specify the type  of disinfectant or procedure, the OSHA original compliance document <sup>269 </sup>suggested that a germicide must be tuberculocidal  to kill the HBV.   To follow the OSHA  compliance document a tuberculocidal disinfectant (e.g., phenolic, and  chlorine) would be needed to clean a blood spill.  However, in  February 1997, OSHA amended its policy and stated that EPA-registered  disinfectants labeled as effective against HIV and HBV would be considered as  appropriate disinfectants &quot;. . . provided such surfaces have not become  contaminated with agent(s) or volumes of or concentrations of agent(s) for  which higher level disinfection is recommended.&quot; When bloodborne pathogens  other than HBV or HIV are of concern, OSHA continues to require use of EPA-registered tuberculocidal  disinfectants or hypochlorite solution (diluted 1:10 or 1:100 with water) <sup>215, 228</sup>.  Studies demonstrate that, in the presence of  large blood spills, a 1:10 final dilution of EPA-registered hypochlorite  solution initially should be used to inactivate bloodborne viruses <sup>63, 235</sup> to minimize risk for infection  to health-care personnel from percutaneous injury during cleanup. </p>



                   
                    
                    <p class="topOPage"><a href="3_2contaminatedDevices.html#">Top of Page</a></p>
                     <p><a name="a5" id="a5"></a> </p>
                       
<h3>Emerging Pathogens (<em>Cryptosporidium, Helicobacter pylori, Escherichia coli</em> O157:H7, Rotavirus, Human Papilloma Virus, Norovirus, Severe Acute Respiratory Syndrome [SARS] Coronavirus)</h3>


<p>Emerging  pathogens are of growing concern to the general public and infection-control  professionals. Relevant pathogens include <em>Cryptosporidium  parvum, Helicobacter pylori, E. coli</em> O157:H7, HIV, HCV, rotavirus,  norovirus, severe acute respiratory syndrome (SARS) coronavirus, multidrug-resistant <em>M. tuberculosis</em>, and nontuberculous  mycobacteria (e.g., <em>M. chelonae</em>). The  susceptibility of each of these pathogens to chemical disinfectants and sterilants  has been studied. With the exceptions discussed below, all of these emerging pathogens  are susceptible to currently available chemical disinfectants and sterilants <sup>270</sup>.</p>

<p><em>Cryptosporidium</em> is resistant to chlorine at concentrations used in potable water.  <em>C.  parvum</em> is not completely inactivated by most disinfectants used in healthcare  including ethyl alcohol <sup>271</sup>, glutaraldehyde <sup>271, 272</sup>, 5.25% hypochlorite <sup>271</sup>, peracetic acid <sup>271</sup>, ortho-phthalaldehyde <sup>271</sup>, phenol <sup>271, 272</sup>, povidone-iodine <sup>271, 272</sup>, and quaternary ammonium compounds<sup>271</sup>.  The only  chemical disinfectants and sterilants able to inactivate greater than 3 log<sub>10</sub>  of <em>C. parvum</em> were 6% and 7.5%  hydrogen peroxide <sup>271</sup>.   Sterilization methods will fully inactivate <em>C. parvum,</em> including steam <sup>271</sup>, EtO <sup>271, 273</sup>, and hydrogen peroxide gas plasma<sup>271</sup>.  Although  most disinfectants are ineffective against <em>C.  parvum</em>, current cleaning and disinfection practices appear satisfactory to  prevent healthcare-associated transmission.   For example, endoscopes are unlikely to be an important vehicle for  transmitting <em>C. parvum</em> because the  results of bacterial studies indicate mechanical cleaning will remove  approximately 10<sup>4</sup> organisms, and drying results in rapid loss of <em>C. parvum</em> viability (e.g., 30 minutes,  2.9 log<sub>10</sub> decrease; and 60 minutes, 3.8 log10 decrease)  <sup>271</sup>.</p>
<p>Chlorine at ~1 ppm has been found  capable of eliminating approximately 4 log10 of <em>E. coli</em> O157:H7 within 1 minute in a suspension test64.  Electrolyzed oxidizing water at 23<sup>o</sup>C  was effective in 10 minutes in producing a 5-log<sub>10</sub> decrease in <em>E. coli</em> O157:H7 inoculated onto kitchen cutting  boards<sup>274</sup>.  The following disinfectants eliminated &gt;5  log<sub>10</sub> of <em>E. coli</em> O157:H7  within 30 seconds: a quaternary ammonium 
  compound, a phenolic, a  hypochlorite (1:10 dilution of 5.25% bleach), and ethano<sup>l53</sup>.  Disinfectants including chlorine compounds can  reduce <em>E. coli</em> O157:H7 experimentally  inoculated onto alfalfa seeds or sprouts <sup>275, 276</sup> or beef carcass surfaces<sup>277</sup>. </p>
<p>Data are limited on the  susceptibility of <em>H. pylori</em> to  disinfectants. Using a suspension test, one study assessed the effectiveness of  a variety of disinfectants against nine strains of <em>H. pylori</em> 60.  Ethanol  (80%) and glutaraldehyde (0.5%) killed all strains within 15 seconds;  chlorhexidine gluconate (0.05%, 1.0%), benzalkonium chloride (0.025%, 0.1%),  alkyldiaminoethylglycine hydrochloride (0.1%), povidone-iodine (0.1%), and  sodium hypochlorite (150 ppm) killed all strains within 30 seconds.  Both ethanol (80%) and glutaraldehyde (0.5%)  retained similar bactericidal activity in the presence of organic matter; the  other disinfectants showed reduced bactericidal activity.  In particular, the bactericidal activity of  povidone-iodine (0.1%) and sodium hypochlorite (150 ppm) markedly decreased in  the presence of dried yeast solution with killing times increased to 5 - 10  minutes and 5 - 30 minutes, respectively.</p>
<p>Immersing biopsy forceps in formalin before obtaining a specimen does not  affect the ability to culture <em>H. pylori</em> from the biopsy specimen <sup>278</sup>.  The  following methods are ineffective for eliminating <em>H. pylori</em> from endoscopes: cleaning with soap and water <sup>119, 279</sup>, immersion in 70% ethanol for 3 minutes<sup>280</sup>, instillation of 70% ethanol<sup>126</sup>, instillation of 30 ml of 83% methanol<sup>279</sup>, and instillation of 0.2% Hyamine solution<sup>281</sup>.  The  differing results with regard to the efficacy of ethyl alcohol against <em>Helicobacter</em> are unexplained.  Cleaning followed by use of 2% alkaline glutaraldehyde  (or automated peracetic acid) has been demonstrated by culture to be effective  in eliminating <em>H. pylori</em> <sup>119, 279, 282</sup>.  Epidemiologic  investigations of patients who had undergone endoscopy with endoscopes  mechanically washed and disinfected with 2.0%&ndash;2.3% glutaraldehyde have revealed no evidence of  person-to-person transmission of <em>H.  pylori</em> <sup>126, 283</sup>.  Disinfection  of experimentally contaminated endoscopes using 2% glutaraldehyde (10-minute,  20-minute, 45-minute exposure times) or the peracetic acid system (with and without active peracetic acid)  has been demonstrated to be effective in eliminating <em>H. pylori</em> <sup>119</sup>.  <em>H. pylori</em> DNA has been detected by PCR  in fluid flushed from endoscope channels after cleaning and disinfection with  2% glutaraldehyde <sup>284</sup>.  The  clinical significance of this finding is unclear.  <em>In  vitro</em> experiments have demonstrated a &gt;3.5-log<sub>10</sub> reduction in <em>H. pylori</em> after exposure to 0.5 mg/L of  free chlorine for 80 seconds<sup>285</sup>. </p>

<p>An  outbreak of healthcare-associated rotavirus gastroenteritis on a pediatric 
unit has been reported <sup>286</sup>.  Person to person  through the hands of health-care workers was proposed as the mechanism of  transmission. Prolonged survival of rotavirus on environmental surfaces (90  minutes to &gt;10 days at room temperature) and hands (&gt;4 hours) has been  demonstrated. Rotavirus suspended in feces can survive longer <sup>287, 288</sup>.  Vectors  have included hands, fomites, air, water, and food <sup>288, 289</sup>.  Products  with demonstrated efficacy (&gt;3 log<sub>10</sub> reduction in virus) against  rotavirus within 1 minute include: 95% ethanol, 70% isopropanol, some  phenolics, 2% glutaraldehyde, 0.35% peracetic acid, and some quaternary  ammonium compounds <sup>59, 290-293</sup>.  In a human  challenge study, a disinfectant spray (0.1% ortho-phenylphenol and 79%  ethanol), sodium hypochlorite (800 ppm free chlorine), and a phenol-based  product (14.7% phenol diluted 1:256 in tapwater) when sprayed onto contaminated  stainless steel disks,  were effective in interrupting  transfer of a human rotavirus from stainless steel disk to fingerpads of  volunteers after an exposure time of 3- 10 minutes.  A quaternary ammonium product (7.05%  quaternary ammonium compound diluted 1:128 in tapwater) and tapwater allowed  transfer of virus <sup>52</sup>.</p>

<p>No data exist  on the inactivation of HPV by alcohol or other disinfectants because in vitro  replication of complete virions has not been achieved. Similarly, little is  known about inactivation of noroviruses (members of the family <em>Caliciviridae</em> and important causes of  gastroenteritis in humans) because they cannot be grown in tissue culture.  Improper disinfection of environmental surfaces contaminated by feces or  vomitus of infected patients is believed to play a role in the spread of  noroviruses in some settings <sup>294-296</sup>.  Prolonged  survival of a norovirus surrogate (i.e., feline calicivirus virus [FCV], a  closely related cultivable virus) has been demonstrated (e.g., at room  temperature, FCV in a dried state survived for 21&ndash;18 days) <sup>297</sup>.   Inactivation studies with FCV have shown the effectiveness of chlorine,  glutaraldehyde, and iodine-based products whereas the quaternary ammonium  compound, detergent, and ethanol failed to inactivate the virus completely. 297  An evaluation  of the effectiveness of several disinfectants against the feline calicivirus  found that bleach diluted to 1000 ppm of available chlorine reduced infectivity  of FCV by 4.5 logs in 1 minute. Other effective (log<sub>10</sub> reduction  factor of &gt;4 in virus) disinfectants included accelerated hydrogen peroxide,  5,000 ppm (3 min); chlorine dioxide, 1,000 ppm chlorine (1 min); a mixture of  four quaternary ammonium compounds, 2,470 ppm (10 min); 79% ethanol with 0.1%  quaternary ammonium compound (3 min); and 75% ethanol (10 min) <sup>298</sup>.  A  quaternary ammonium compound exhibited activity against feline calicivirus  supensions dried on hard surface carriers in 10 minutes <sup>299</sup>.  Seventy  percent ethanol and 70% 1-propanol reduced FCV by a 3&ndash;4-log10  reduction in 30 seconds 300.  </p>
<p>CDC announced  that a previously unrecognized human virus from the coronavirus family is the  leading hypothesis for the cause of a described syndrome of SARS 301. Two coronaviruses that are known  to infect humans cause one third of common colds and can cause gastroenteritis.  The virucidal efficacy of chemical germicides against coronavirus has been  investigated. A study of disinfectants against coronavirus 229E found several that  were effective after a 1-minute contact time; these included sodium  hypochlorite (at a free chlorine concentration of 1,000 ppm and 5,000 ppm), 70%  ethyl alcohol, and povidone-iodine (1% iodine) <sup>186</sup>.  In another study, 70% ethanol, 50%  isopropanol, 0.05% benzalkonium chloride, 50 ppm iodine in iodophor, 0.23%  sodium chlorite, 1% cresol soap and 0.7% formaldehyde inactivated &gt;3 logs of  two animal coronaviruses (mouse hepatitis virus, canine coronavirus) after a 10-minute  exposure time <sup>302</sup>.  The activity of povidone-iodine has been  demonstrated against human coronaviruses 229E and OC43 <sup>303</sup>.   A study also showed complete inactivation of the SARS coronavirus by 70%  ethanol and povidone-iodine with an exposure times of 1 minute and 2.5%  glutaraldehyde with an exposure time of 5 minute 304.  Because the SARS coronavirus is stable in  feces and urine at room temperature for at least 1&ndash;2 days (WHO, 2003; <a href="http://www.who.int/csr/sars/survival_2003_05_04/en/index.html">http://www.who.int/csr/sars/survival_2003_05_04/en/index.html</a>),  surfaces might be a possible source of contamination and lead to infection with  the SARS coronavirus and should be disinfected. Until more precise  information is available, environments in which SARS patients are housed should  be considered heavily contaminated, and rooms and equipment should be thoroughly  disinfected daily and after the patient is discharged. EPA-registered  disinfectants or 1:100 dilution of household bleach and water should be used for  surface disinfection and disinfection on noncritical patient-care equipment.  High-level disinfection and sterilization of semicritical and critical medical  devices, respectively, does not need to be altered for patients with known or  suspected SARS. </p>
<p>Free-living amoeba can be pathogenic  and can harbor agents of pneumonia such as <em>Legionella  pneumophila</em>.  Limited studies have  shown that 2% glutaraldehyde and peracetic acid do not completely inactivate <em>Acanthamoeba polyphaga</em> in a 20-minute  exposure time for high-level disinfection.   If amoeba are found to contaminate instruments and facilitate infection,  longer immersion times or other disinfectants may need to be considered <sup>305</sup>. </p>


                   
                    <p class="topOPage"><a href="3_2contaminatedDevices.html#">Top of Page</a></p>
                  
                    </div>

<div class="module rounders grey multiPage-horiz" id="tableOfContent">
<div class="inner">
<div class="t"></div>

<div class="hd">
<h4><span><a href="3_1deLaparoArthro.html">Previous Page</a></span>
<span class="nextLink"><a href="3_3inactivBioAgents.html">Next Page</a></span></h4>
</div>

<div class="bd"><span><a href="toc.html">Table of Contents</a></span></div>
</div>

<div class="b">
<div></div>
</div>
</div>                       
                       
					<!-- InstanceEndEditable -->
					<!-- /end .main-inner --></div>
					
					<div id="linkPolicy">&nbsp;</div>
				<!-- /end #content-main--></div>
				
			<!-- /end #content-inner --></div>
			
			<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
			<div id="content-secondary">
				<div class="pageOptions">
					<div class="pageOptions-inner">
						<!-- If you're seeing this, the text-sizer include is depricated and the server-side-include reference should be removed from all pages -->
						<ul id="services" class="services">
							<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
						</ul>
						<!-- InstanceBeginEditable name="local-options" -->
					
                    <ul class="services top-divide">
						  <li class="pdf"><a class="noDecoration" href="https://www.cdc.gov/hicpac/pdf/Disinfection_Sterilization/Pages21_25Disinfection_Nov_2008.pdf" title="PDF – 101 KB">Download page</a></li>
					    </ul>
                    
                   
					<!-- InstanceEndEditable -->
						<!-- InstanceBeginEditable name="languages" -->
					 
				<!-- InstanceEndEditable -->
					</div>
				</div>
				
				
				<!-- InstanceBeginEditable name="gov-delivery" -->
			
			<!-- InstanceEndEditable -->
				<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
			<!-- /end #content-secondary --></div>
			
		<!-- /end #content --></div>
		
		<div class="preFoot">
			<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
			<div class="pageOptions-horizontal">
				<ul class="services">
					<li class="print"><a href="javascript:window.print();">Print</a></li>

					<!-- InstanceBeginEditable name="local-options-horizontal" -->
				
				<!-- InstanceEndEditable -->
				</ul>
			</div>
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
			<ul>
				<li class="last-reviewed">Page last reviewed: <span>December 29, 2009</span></li>
				<li class="last-updated">Page last updated: <span>December 29, 2009</span></li>
				 <li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a><br /> <a href="../../ncezid.1.html">National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)</a><br /> <a href="../../ncezid/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP)</a></li>

			</ul>
		<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>
